NeuroOne Medical Technolo... (NMTC)
NeuroOne Medical Statistics
Share Statistics
NeuroOne Medical has 30.86M shares outstanding. The number of shares has increased by 18.94% in one year.
| Shares Outstanding | 30.86M |
| Shares Change (YoY) | 18.94% |
| Shares Change (QoQ) | 0.1% |
| Owned by Institutions (%) | 6.05% |
| Shares Floating | 26.76M |
| Failed to Deliver (FTD) Shares | 350 |
| FTD / Avg. Volume | 0.16% |
Short Selling Information
The latest short interest is 95.52K, so 0.31% of the outstanding shares have been sold short.
| Short Interest | 95.52K |
| Short % of Shares Out | 0.31% |
| Short % of Float | 0.36% |
| Short Ratio (days to cover) | 0.6 |
Valuation Ratios
The PE ratio is -2.15 and the forward PE ratio is -4.11. NeuroOne Medical's PEG ratio is 0.07.
| PE Ratio | -2.15 |
| Forward PE | -4.11 |
| PS Ratio | 7.67 |
| Forward PS | 1.8 |
| PB Ratio | 32.23 |
| P/FCF Ratio | -2.38 |
| PEG Ratio | 0.07 |
Enterprise Valuation
NeuroOne Medical Technologies Corporation has an Enterprise Value (EV) of 11M.
| EV / Earnings | -0.89 |
| EV / Sales | 3.18 |
| EV / EBITDA | -0.93 |
| EV / EBIT | -0.93 |
| EV / FCF | -0.99 |
Financial Position
The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.32.
| Current Ratio | 2.09 |
| Quick Ratio | 0.9 |
| Debt / Equity | 0.32 |
| Total Debt / Capitalization | 24.04 |
| Cash Flow / Debt | -42.33 |
| Interest Coverage | -51.91 |
Financial Efficiency
Return on equity (ROE) is -14.99% and return on capital (ROIC) is -1098.46%.
| Return on Equity (ROE) | -14.99% |
| Return on Assets (ROA) | -2.29% |
| Return on Capital (ROIC) | -1098.46% |
| Revenue Per Employee | $203,117.82 |
| Profits Per Employee | $-724,594.71 |
| Employee Count | 17 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 0.9 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -27.5% in the last 52 weeks. The beta is 0.65, so NeuroOne Medical's price volatility has been higher than the market average.
| Beta | 0.65 |
| 52-Week Price Change | -27.5% |
| 50-Day Moving Average | 1.06 |
| 200-Day Moving Average | 0.9 |
| Relative Strength Index (RSI) | 35.63 |
| Average Volume (20 Days) | 216.07K |
Income Statement
In the last 12 months, NeuroOne Medical had revenue of 3.45M and earned -12.32M in profits. Earnings per share was -0.46.
| Revenue | 3.45M |
| Gross Profit | 1.08M |
| Operating Income | -11.89M |
| Net Income | -12.32M |
| EBITDA | -11.84M |
| EBIT | -11.89M |
| Earnings Per Share (EPS) | -0.46 |
Balance Sheet
The company has 1.46M in cash and 260.16K in debt, giving a net cash position of 1.2M.
| Cash & Cash Equivalents | 1.46M |
| Total Debt | 260.16K |
| Net Cash | 1.2M |
| Retained Earnings | -75M |
| Total Assets | 6.49M |
| Working Capital | 4.14M |
Cash Flow
In the last 12 months, operating cash flow was -11.01M and capital expenditures -120.2K, giving a free cash flow of -11.13M.
| Operating Cash Flow | -11.01M |
| Capital Expenditures | -120.2K |
| Free Cash Flow | -11.13M |
| FCF Per Share | -0.42 |
Margins
Gross margin is 31.27%, with operating and profit margins of -344.26% and -356.74%.
| Gross Margin | 31.27% |
| Operating Margin | -344.26% |
| Pretax Margin | -356.74% |
| Profit Margin | -356.74% |
| EBITDA Margin | -342.96% |
| EBIT Margin | -344.26% |
| FCF Margin | -322.39% |
Dividends & Yields
NMTC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -52.87% |
| FCF Yield | -41.46% |
Analyst Forecast
Currently there are no analyst rating for NMTC.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Apr 1, 2021. It was a backward split with a ratio of 1:3.
| Last Split Date | Apr 1, 2021 |
| Split Type | backward |
| Split Ratio | 1:3 |
Scores
| Altman Z-Score | -12.78 |
| Piotroski F-Score | 3 |